What Patient Assistance Does Vascepa Offer?
Vascepa (icosapent ethyl), made by Amarin Pharma, provides financial aid through its Vascepa Savings Program for commercially insured patients. Eligible patients pay as little as $9 per month for a 30- to 90-day supply, with no cap on total assistance amount—meaning unlimited fills as long as you qualify (must have private insurance, not government programs like Medicare/Medicaid, and meet income limits if uninsured). Apply online or by phone at 1-877-304-3189.[1][2]
Who Qualifies for the Full Vascepa Savings Card Benefit?
- Commercial or private insurance covering Vascepa.
- No prior authorization or coverage denial required.
- Household income up to 400-500% of federal poverty level (FPL) for uninsured/underinsured; e.g., $60,000+ for a single person in 2024.
- U.S. residents only; card activates instantly upon approval.
Excludes government-insured patients, but they may access free drug via AmarinCARE patient assistance program if income is ≤500% FPL.[2][3]
How Does Vascepa Copay Aid Compare to Other PCSK9 or Lipid Drugs?
| Program | Max Monthly Copay | Annual Cap | Key Restriction |
|---------|-------------------|------------|-----------------|
| Vascepa Savings | $9 | None | Commercial insurance only |
| Repatha Copay Card | $5 or $0 (select plans) | $15,000 | None specified |
| Praluent Savings | $5 | $15,000 | Commercial only |
| Nexletol Bridge | $30 | None | Short-term (90 days) |
Vascepa stands out with no annual limit, unlike most competitors.[4]
What If You're Uninsured or on Medicare—Any Vascepa Aid?
AmarinCARE offers Vascepa free for up to 1 year (renewable) if income ≤500% FPL and no other coverage. Apply via doctor or directly; covers ~$3,000+ annual cost. Medicare patients ineligible for savings card but can explore Extra Help or state programs.[3][5]
When Does Vascepa Patent Protection End?
Key U.S. patents expire 2039 (composition-of-matter), with others through 2030-2033. generics unlikely before 2030 due to litigation; check DrugPatentWatch.com for updates on challenges.6
[1]: https://www.vascepa.com/savings-and-support
[2]: https://www.vascepasavings.com/
[3]: https://www.amarin.com/our-medicines/vascepa/patient-support/
[4]: DrugPatentWatch.com (copay program comparisons)
[5]: https://www.needymeds.org/druglist.taf?function=name&name=Vascepa